Health Care·Life Sciences Tools & Services·$8.5B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.84 | N/A | +11.55% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.84 | N/A | +11.55% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Management expressed confidence in the company's ability to grow despite market challenges. They highlighted strong product demand and ongoing investments.
Management highlighted strong demand for their products.
They noted ongoing investments in innovation and development.
There was an emphasis on maintaining operational efficiency.
Bio-Techne Corp's earnings report showed a positive surprise on EPS, which likely contributed to the stock's 2.94% increase. The management's focus on product demand and innovation suggests a commitment to growth. However, the lack of revenue details and guidance leaves some uncertainty for investors.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
EXXON MOBIL CORP
Oct 28, 2016